Tutkijat / Kuopio  | Airaksinen, O(lavi) |
 | Alhava, E. |
 | Alhonen, L. |
 | Atalay, M(ustafa) |
 | Cederberg, H. |
 | Dunkel, L(eo) |
 | Eskelinen, M(atti) |
 | Giniatullin, R. |
 | Gröhn, O(lli) |
 | Harno, K. |
 | Hartikainen, J(aana). |
 | Hartikainen, J(uha). |
 | Harvima, I. |
 | Hiltunen, M(ikko) |
 | Jääskeläinen, J(uha) E. |
 | Jäkälä, P(ekka) |
 | Jänne, J. |
 | Jantunen, E(sa) |
 | Järvinen, R. |
 | Julkunen, P. |
 | Kaikkonen, M(inna) U. |
 | Kauhanen, J(ussi) |
 | Kivipelto, M(iia) |
 | Koistinaho, M. |
 | Koivisto, T(imo) |
 | Kokki, H. |
 | Könönen, M. |
 | Kosma, V(eli)-M(atti) |
 | Kröger, H. |
 | Kurl, S(udhir) |
 | Kuusisto, J(ohanna) |
 | Laakso, M(arkku) |
 | Lakka, T(imo) A. |
 | Lapinlampi, N(iina) |
 | Laukkanen, J(ari) (UEF/KSSHP) |
 | Levonen, A(nna)-L(iisa) |
 | Lindgren, A(ntti) E. |
 | Löppönen, H(eikki) |
 | Mannermaa, A. |
 | Manninen, H. |
 | Mecklin, J(ukka)-P(ekka) |
 | Moilanen, L(eena) |
 | Mönkkönen, J. |
 | Mykkänen, H. |
 | Nuutinen, J. |
 | Paajanen, H. |
 | Paananen, J. |
 | Palvimo, J.J. |
 | Pelkonen, J(ukka) |
 | Pihlajamäki, J(ussi) |
 | Pihlajamäki, M. |
 | Pitkänen, A(sla) |
 | Punnonen, K. |
 | Raatikainen K |
 | Rauramaa, R. |
 | Rissanen, T.T. |
 | Roine, R(isto) P. |
 | Ryynänen, O.P. |
 | Saarikoski, S. |
 | Schwab, U(rsula) |
 | Sivenius, J. |
 | Soininen, H(ilkka) |
 | Soininen, P(asi) |
 | Sorri, I. |
 | Stancakova, A(lena) |
 | Sulkava, R. |
 | Sund, R(eijo) |
 | Tammi, M. |
 | Tanila, H(eikki) |
 | Tiihonen, J(ari) |
 | Uusaro, A. |
 | Uusitupa, M. |
 | Vanninen, R. |
 | Vaskilampi, T. |
 | Viinamäki, H(eimo) |
 | Virtanen, M(arianna) |
 | Voutilainen, R(aimo) |
 | Voutilainen, S(ari) |
 | Wahlfors, J. |
 | Wirth, T. |
 | Wong, G. |
 | Ylä-Herttuala, S(eppo) | Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds |
| | Mast Cells and Sensory Nerves Contribute to Neurogenic Inflammation and Pruritus in Chronic Skin Inflammation | Harvima, I. | 43 days | save |  |  |  |  |
| Mast Cells Are a Marked Source for Complement C3 Products That Associate with Increased CD11b-Positive Cells in Keratinocyte Skin Carcinomas | Harvima, I. | 43 days | save |  |  |  |  |
| Mast cell chymase degrades fibrinogen and fibrin | Harvima, I. | 43 days | save |  |  |  |  |
| Increase in FoxP3-positive Cells and Their Contacts with Mast Cells in Köbner-negative Patients with Psoriasis after Tape-stripping | Harvima, I. | 43 days | save |  |  |  |  |
| Mast cell-neural interactions contribute to pain and itch | Harvima, I. | 43 days | save |  |  |  |  |
| Accuracy and reliability of a hand-held in vivo skin indentation device to assess skin elasticity | Harvima, I. | 43 days | save |  |  |  |  |
| Immunoreactivity to CYP24A1, but not vitamin D receptor, is increased in mast cells of keratinocyte skin cancers | Harvima, I. | 43 days | save |  |  |  |  |
| CD40 Ligand Is Increased in Mast Cells in Psoriasis and Actinic Keratosis but Less So in Epithelial Skin Carcinomas | Harvima, I. | 43 days | save |  |  |  |  |
| Complement C3 is expressed by mast cells in cutaneous vasculitis and is degraded by chymase | Harvima, I. | 43 days | save |  |  |  |  |
| Immediate Wheal Reactivity to Autologous Sweat in Atopic Dermatitis Is Associated with Clinical Severity, Serum Total and Specific IgE and Sweat Tryptase Activity | Harvima, I. | 43 days | save |  |  |  |  |
| Increased mitogen-stimulated lymphocyte proliferation is associated with the clinical response in major depressive disorder in women: A follow-up study | Harvima, I. | 43 days | save |  |  |  |  |
| Mast cell chymase in experimentally induced psoriasis | Harvima, I. | 43 days | save |  |  |  |  |
| Epidermal Expression of Filaggrin/Profilaggrin Is Decreased in Atopic Dermatitis: Reverse Association With Mast Cell Tryptase and IL-6 but Not With Clinical Severity | Harvima, I. | 43 days | save |  |  |  |  |
| Mast cell tryptase and chymase in the progress of cutaneous vasculitis | Harvima, I. | 43 days | save |  |  |  |  |
| Mast cells express CYP27A1 and CYP27B1 in epithelial skin cancers and psoriasis | Harvima, I. | 43 days | save |  |  |  |  |
| Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma | Harvima, I. | 43 days | save |  |  |  |  |
| Experimentally induced psoriatic lesions associate with rapid but transient decrease in interleukin-33 immunostaining in epidermis | Harvima, I. | 43 days | save |  |  |  |  |
| Increased numbers of tryptase-positive mast cells in the healthy and sun-protected skin of tobacco smokers | Harvima, I. | 43 days | save |  |  |  |  |
| Decrease in chymase activity is associated with increase in IL-6 expression in mast cells in atopic dermatitis | Harvima, I. | 43 days | save |  |  |  |  |
| Molecular targets on mast cells and basophils for novel therapies | Harvima, I. | 43 days | save |  |  |  |  |
| Reduced serum adiponectin levels in alexithymia | Harvima, I. | 43 days | save |  |  |  |  |
| Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor | Harvima, I. | 43 days | save |  |  |  |  |
| Glucocorticoids and aetiopathogenesis of depression | Harvima, I. | 43 days | save |  |  |  |  |
| Anti-apoptotic BFL-1 is the major effector in activation-induced human mast cell survival | Harvima, I. | 43 days | save |  |  |  |  |
| OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity | Harvima, I. | 43 days | save |  |  |  |  |
| Stress, the neuroendocrine system and mast cells: current understanding of their role in psoriasis | Harvima, I. | 43 days | save |  |  |  |  |
| Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder | Harvima, I. | 43 days | save |  |  |  |  |
| Mast cells as regulators of skin inflammation and immunity | Harvima, I. | 43 days | save |  |  |  |  |
| Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitro | Harvima, I. | 43 days | save |  |  |  |  |
| The BH3-mimetic ABT-737 induces mast cell apoptosis in vitro and in vivo: potential for therapeutics | Harvima, I. | 43 days | save |  |  |  |  |
| Role of mast cells and sensory nerves in skin inflammation | Harvima, I. | 43 days | save |  |  |  |  |
| Increased mast cell expression of PAR-2 in skin inflammatory diseases and release of IL-8 upon PAR-2 activation | Harvima, I. | 43 days | save |  |  |  |  |
| Human mast cells adhere to and migrate on epithelial and vascular basement membrane laminins LM-332 and LM-511 via alpha3beta1 integrin | Harvima, I. | 43 days | save |  |  |  |  |
| Induction of matrix metalloproteinase-9 in keratinocytes by histamine | Harvima, I. | 43 days | save |  |  |  |  |
| Is there a role for mast cells in psoriasis? | Harvima, I. | 43 days | save |  |  |  |  |
| Cervical squamous carcinoma cells are resistant to the combined action of tumor necrosis factor-alpha and histamine whereas normal keratinocytes undergo cytolysis | Harvima, I. | 43 days | save |  |  |  |  |
| Expression of 15-lipoxygenase type-1 in human mast cells | Harvima, I. | 43 days | save |  |  |  |  |
| The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma | Harvima, I. | 43 days | save |  |  |  |  |
| Juvenile-onset neuronal ceroid lipofuscinosis with infantile CLN1 mutation and palmitoyl-protein thioesterase deficiency | Harvima, I. | 43 days | save |  |  |  |  |
| Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma | Harvima, I. | 43 days | save |  |  |  |  |
| Histamine, but not leukotriene C4, is an essential mediator in cold urticaria wheals | Harvima, I. | 43 days | save |  |  |  |  |
| Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion | Harvima, I. | 43 days | save |  |  |  |  |
| Hyaluronic acid inhibits the adherence and growth of monolayer keratinocytes but does not affect the growth of keratinocyte epithelium | Harvima, I. | 43 days | save |  |  |  |  |
| How should the care of dermatological diseases be developed? | Harvima, I. | 43 days | save |  |  |  |  |
| CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma | Harvima, I. | 43 days | save |  |  |  |  |
| Effect of temporin A modifications on its cytotoxicity and antimicrobial activity | Harvima, I. | 43 days | save |  |  |  |  |
| Efficacy of dietary hempseed oil in patients with atopic dermatitis | Harvima, I. | 43 days | save |  |  |  |  |
| Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors | Harvima, I. | 43 days | save |  |  |  |  |
| Study of innervation, sensory neuropeptides, and serotonin in murine contact allergic skin | Harvima, I. | 43 days | save |  |  |  |  |
| The production of collagen and the activity of mast-cell chymase increase in human skin after irradiation therapy | Harvima, I. | 43 days | save |  |  |  |  |
|  report | next » | |
|